Thomas John Dietz Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Thomas John Dietz.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Thomas John Dietz. Thomas John Dietz is Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and Director in LEAP THERAPEUTICS, INC. ($LPTX).

Latest Insider Trading Transactions of Thomas John Dietz

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, EIGR, LPTX, PRTK

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 12 2021	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	8.50	1,000	8,500	37,500	36.5 K to 37.5 K (+2.74 %)
Apr 12 2021	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	8.48	1,500	12,720	36,500	35 K to 36.5 K (+4.29 %)
Mar 15 2021	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	9.99	20,000	199,800	20,000
Mar 15 2021	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Grant	A	0.00	5,000	0	35,000	30 K to 35 K (+16.67 %)
Feb 22 2021	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	A	7.61	7,000	53,270	7,000
Feb 22 2021	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Grant	A	0.00	9,000	0	30,000	21 K to 30 K (+42.86 %)
Jan 06 2021	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	2.18	37,300	81,314	37,300
Aug 12 2020	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	1.97	12,500	24,625	12,500
Apr 13 2020	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	1.69	12,500	21,125	12,500
Mar 17 2020	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	4.95	1,000	4,950	30,000	29 K to 30 K (+3.45 %)
Mar 13 2020	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	5.60	20,000	112,000	20,000
Mar 13 2020	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Grant	A	0.00	5,000	0	29,000	24 K to 29 K (+20.83 %)
Mar 04 2020	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	2.94	25,000	73,500	25,000
Feb 21 2020	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	A	3.51	7,000	24,570	7,000
Feb 21 2020	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Grant	A	0.00	9,000	0	21,000	12 K to 21 K (+75.00 %)
Jan 13 2020	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	13.94	4,000	55,760	24,000	20 K to 24 K (+20.00 %)
Jun 12 2019	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	1.39	15,000	20,850	15,000
Apr 23 2019	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	11.10	5,000	55,495	20,000	15 K to 20 K (+33.33 %)
Apr 22 2019	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	11.05	5,000	55,250	15,000	10 K to 15 K (+50.00 %)
Apr 22 2019	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	11.05	5,000	55,250	15,000	10 K to 15 K (+50.00 %)
Mar 25 2019	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	13.41	20,000	268,200	20,000
Mar 25 2019	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	13.41	20,000	268,200	20,000
Feb 28 2019	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	A	7.23	5,000	36,150	5,000
Feb 28 2019	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Grant	A	0.00	7,500	0	12,000	4.5 K to 12 K (+166.67 %)
Feb 20 2019	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Sell	S	7.14	3,000	21,420	4,500	7.5 K to 4.5 K (-40.00 %)
Jan 03 2019	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	2.00	9,375	18,750	9,375
Dec 26 2018	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Sell	S	5.01	9,330	46,743	7,500	16.8 K to 7.5 K (-55.44 %)
Dec 20 2018	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	9.98	5,000	49,900	10,000	5 K to 10 K (+100.00 %)
Dec 10 2018	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Buy	P	11.26	5,000	56,300	5,000	0 to 5 K
Apr 20 2018	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	7.66	11,250	86,175	11,250
Mar 16 2018	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	9.50	10,000	95,000	10,000
Feb 16 2018	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	A	14.15	5,000	70,750	5,000
Feb 16 2018	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Grant	A	0.00	7,500	0	16,830	9.3 K to 16.8 K (+80.39 %)
Feb 07 2018	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Sell	S	14.22	2,100	29,862	9,330	11.4 K to 9.3 K (-18.37 %)
Apr 13 2017	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	8.50	10,000	85,000	10,000
Feb 06 2017	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	A	15.10	6,000	90,600	6,000
Feb 06 2017	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Grant	A	0.00	6,000	0	11,430	5.4 K to 11.4 K (+110.50 %)
Jan 23 2017	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Jan 23 2017	LPTX	LEAP THERAPEUTICS, ...	Dietz Thomas John	Director	Option Exercise	A	9.90	11,000	108,900	11,000
Apr 01 2016	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	15.75	23,000	362,250	23,000
Apr 01 2016	EIGR	Eiger BioPharmaceu ...	Dietz Thomas John	Director	Option Exercise	A	15.75	25,000	393,750	25,000
Feb 08 2016	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	A	14.05	12,000	168,600	12,000
Oct 30 2014	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	D	56.88	1,666	94,762	0
Oct 30 2014	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	D	41.16	2,083	85,736	0
Oct 30 2014	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Grant	A	0.00	5,430	0	5,430	0 to 5.4 K
Apr 11 2013	PRTK	Paratek Pharmaceut ...	Dietz Thomas John	Director	Option Exercise	A	4.76	25,000	119,000	25,000

Page: 1